GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neural Therapeutics Inc (FRA:M6B) » Definitions » Net Margin %

Neural Therapeutics (FRA:M6B) Net Margin % : 0.00% (As of Jan. 2025)


View and export this data going back to 2025. Start your Free Trial

What is Neural Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Neural Therapeutics's Net Income for the three months ended in Jan. 2025 was €-0.08 Mil. Neural Therapeutics's Revenue for the three months ended in Jan. 2025 was €0.00 Mil. Therefore, Neural Therapeutics's net margin for the quarter that ended in Jan. 2025 was 0.00%.

The historical rank and industry rank for Neural Therapeutics's Net Margin % or its related term are showing as below:


FRA:M6B's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -110.45
* Ranked among companies with meaningful Net Margin % only.

Neural Therapeutics Net Margin % Historical Data

The historical data trend for Neural Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neural Therapeutics Net Margin % Chart

Neural Therapeutics Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Net Margin %
- - - - -

Neural Therapeutics Quarterly Data
Jul20 Jul21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neural Therapeutics's Net Margin %

For the Biotechnology subindustry, Neural Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neural Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neural Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Neural Therapeutics's Net Margin % falls into.


;
;

Neural Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Neural Therapeutics's Net Margin for the fiscal year that ended in Jul. 2024 is calculated as

Net Margin=Net Income (A: Jul. 2024 )/Revenue (A: Jul. 2024 )
=-0.448/0
= %

Neural Therapeutics's Net Margin for the quarter that ended in Jan. 2025 is calculated as

Net Margin=Net Income (Q: Jan. 2025 )/Revenue (Q: Jan. 2025 )
=-0.078/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neural Therapeutics  (FRA:M6B) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Neural Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Neural Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neural Therapeutics Business Description

Traded in Other Exchanges
Address
130 Adelaide Street, Suite 3002, Toronto, ON, CAN, M5H 3P5
Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.

Neural Therapeutics Headlines

No Headlines